CN Stock MarketDetailed Quotes

Shenyang Xingqi Pharmaceutical (300573)

Watchlist
  • 67.19
  • -0.62-0.91%
Market Closed Apr 17 15:00 CST
16.56BMarket Cap25.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenyang Xingqi Pharmaceutical (300573) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
32.27%1.9B
30.38%1.16B
53.24%536.14M
32.42%1.94B
30.27%1.44B
30.10%891.8M
22.10%349.88M
17.42%1.47B
10.02%1.1B
14.14%685.47M
Operating revenue
32.27%1.9B
30.38%1.16B
53.24%536.14M
32.42%1.94B
30.27%1.44B
30.10%891.8M
22.10%349.88M
17.42%1.47B
10.02%1.1B
14.14%685.47M
Other operating revenue
----
8.95%12.65M
----
-30.06%19.49M
----
-18.82%11.61M
----
20.08%27.86M
----
937.96%14.3M
Total operating cost
9.79%1.22B
12.33%779.97M
17.29%367.43M
28.73%1.54B
23.05%1.11B
18.27%694.36M
19.36%313.25M
18.25%1.2B
18.50%899.95M
30.28%587.09M
Operating cost
14.25%355.47M
15.39%224.7M
27.25%106.4M
26.82%421.11M
25.61%311.14M
20.15%194.73M
21.42%83.61M
24.99%332.06M
24.11%247.7M
33.80%162.07M
Operating tax surcharges
35.94%26.88M
36.88%16.27M
88.30%7.64M
54.91%25.42M
57.42%19.77M
50.56%11.89M
52.81%4.06M
4.95%16.41M
2.85%12.56M
3.25%7.9M
Operating expense
7.46%555.47M
10.48%366.1M
12.00%168.01M
31.79%705.49M
25.90%516.89M
21.93%331.38M
11.98%150.01M
15.51%535.31M
19.80%410.56M
34.49%271.78M
Administration expense
-1.07%118.94M
-1.02%77.9M
-3.46%37.36M
10.23%170.29M
6.84%120.23M
10.62%78.69M
28.60%38.7M
17.08%154.49M
-6.68%112.53M
-3.05%71.14M
Financial expense
2,613.77%3.91M
410.29%3.24M
179.65%951.34K
115.66%974.81K
96.85%-155.63K
70.26%-1.04M
34.45%-1.19M
23.06%-6.23M
18.43%-4.95M
16.26%-3.51M
-Interest expense (Financial expense)
-6.46%3.8M
23.92%2.8M
147.88%1.5M
297.30%5.71M
398.48%4.07M
560.16%2.26M
284.14%605.37K
53.38%1.44M
1.21%815.91K
-43.35%342.7K
-Interest Income (Financial expense)
60.98%-1.85M
61.86%-1.39M
61.11%-718.88K
28.51%-5.66M
19.81%-4.75M
7.64%-3.65M
9.55%-1.85M
20.34%-7.91M
22.84%-5.92M
25.88%-3.95M
Research and development
11.21%155.12M
16.59%91.76M
23.65%47.07M
31.90%220.66M
14.75%139.48M
1.28%78.7M
32.72%38.07M
14.89%167.3M
34.39%121.55M
53.58%77.71M
Credit Impairment Loss
-46.17%-4.78M
67.87%-1.15M
-131.18%-370.83K
-23.77%-4.62M
25.05%-3.27M
20.03%-3.58M
199.72%1.19M
-263.51%-3.73M
-11.89%-4.36M
-121.29%-4.47M
Asset Impairment Loss
-150.89%-7.77M
-339.93%-7.64M
-463.56%-6.4M
58.81%-3.42M
-12.44%-3.1M
32.74%-1.74M
134.36%1.76M
-88.28%-8.29M
-5,545.02%-2.75M
-673.67%-2.58M
Other net revenue
-23.74%15.54M
15.32%13.02M
-11.22%9.44M
205.09%25.31M
195.14%20.38M
289.58%11.29M
949.02%10.63M
-42.65%8.3M
-11.51%6.9M
-11.54%2.9M
Invest income
----
----
----
---24.24K
---24.24K
---24.24K
----
----
----
----
Asset deal income
-26.66%74.56K
-51.62%74.8K
--32.1K
-2,506.63%-978.36K
421.82%101.67K
589.43%154.62K
----
-108.92%-37.53K
-2,061.53%-31.59K
-2,061.53%-31.59K
Other revenue
5.04%28.01M
31.94%21.74M
110.64%16.18M
68.71%34.35M
89.79%26.66M
65.02%16.48M
51.66%7.68M
4.53%20.36M
20.59%14.05M
77.24%9.98M
Operating profit
99.67%703.47M
89.61%395.79M
277.02%178.15M
53.61%424.75M
66.33%352.31M
106.09%208.74M
106.63%47.25M
10.56%276.52M
-16.14%211.82M
-33.89%101.28M
Add:Non operating Income
-25.70%183.76K
232.97%83.76K
--905
205.45%291.89K
189.07%247.33K
-67.57%25.16K
----
-96.84%95.56K
-95.86%85.56K
15.26%77.56K
Less:Non operating expense
1.25%14.88M
32.40%11.17M
-89.05%612.66K
158.22%30.01M
59.56%14.7M
1.67%8.44M
408.65%5.6M
-40.12%11.62M
-46.44%9.21M
-42.83%8.3M
Total profit
103.86%688.77M
92.04%384.71M
326.19%177.53M
49.07%395.03M
66.69%337.86M
115.26%200.33M
90.40%41.66M
13.38%264.99M
-14.64%202.69M
-32.93%93.06M
Less:Income tax cost
90.81%89.86M
60.88%49.88M
358.07%31.64M
128.27%56.97M
131.32%47.1M
484.20%31M
173.19%6.91M
13.27%24.96M
-41.20%20.36M
-70.71%5.31M
Net profit
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
Net profit from continuing operation
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
Net profit of parent company owners
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
Earning per share
Basic earning per share
105.04%2.44
97.10%1.36
315.00%0.83
40.58%1.94
13.33%1.19
35.29%0.69
25.00%0.2
-19.77%1.38
-35.98%1.05
-62.77%0.51
Diluted earning per share
105.04%2.44
97.10%1.36
315.00%0.83
39.86%1.93
13.33%1.19
35.29%0.69
25.00%0.2
-19.77%1.38
-35.98%1.05
-62.77%0.51
Other composite income
Total composite income
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
Total composite income of parent company owners
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 32.27%1.9B30.38%1.16B53.24%536.14M32.42%1.94B30.27%1.44B30.10%891.8M22.10%349.88M17.42%1.47B10.02%1.1B14.14%685.47M
Operating revenue 32.27%1.9B30.38%1.16B53.24%536.14M32.42%1.94B30.27%1.44B30.10%891.8M22.10%349.88M17.42%1.47B10.02%1.1B14.14%685.47M
Other operating revenue ----8.95%12.65M-----30.06%19.49M-----18.82%11.61M----20.08%27.86M----937.96%14.3M
Total operating cost 9.79%1.22B12.33%779.97M17.29%367.43M28.73%1.54B23.05%1.11B18.27%694.36M19.36%313.25M18.25%1.2B18.50%899.95M30.28%587.09M
Operating cost 14.25%355.47M15.39%224.7M27.25%106.4M26.82%421.11M25.61%311.14M20.15%194.73M21.42%83.61M24.99%332.06M24.11%247.7M33.80%162.07M
Operating tax surcharges 35.94%26.88M36.88%16.27M88.30%7.64M54.91%25.42M57.42%19.77M50.56%11.89M52.81%4.06M4.95%16.41M2.85%12.56M3.25%7.9M
Operating expense 7.46%555.47M10.48%366.1M12.00%168.01M31.79%705.49M25.90%516.89M21.93%331.38M11.98%150.01M15.51%535.31M19.80%410.56M34.49%271.78M
Administration expense -1.07%118.94M-1.02%77.9M-3.46%37.36M10.23%170.29M6.84%120.23M10.62%78.69M28.60%38.7M17.08%154.49M-6.68%112.53M-3.05%71.14M
Financial expense 2,613.77%3.91M410.29%3.24M179.65%951.34K115.66%974.81K96.85%-155.63K70.26%-1.04M34.45%-1.19M23.06%-6.23M18.43%-4.95M16.26%-3.51M
-Interest expense (Financial expense) -6.46%3.8M23.92%2.8M147.88%1.5M297.30%5.71M398.48%4.07M560.16%2.26M284.14%605.37K53.38%1.44M1.21%815.91K-43.35%342.7K
-Interest Income (Financial expense) 60.98%-1.85M61.86%-1.39M61.11%-718.88K28.51%-5.66M19.81%-4.75M7.64%-3.65M9.55%-1.85M20.34%-7.91M22.84%-5.92M25.88%-3.95M
Research and development 11.21%155.12M16.59%91.76M23.65%47.07M31.90%220.66M14.75%139.48M1.28%78.7M32.72%38.07M14.89%167.3M34.39%121.55M53.58%77.71M
Credit Impairment Loss -46.17%-4.78M67.87%-1.15M-131.18%-370.83K-23.77%-4.62M25.05%-3.27M20.03%-3.58M199.72%1.19M-263.51%-3.73M-11.89%-4.36M-121.29%-4.47M
Asset Impairment Loss -150.89%-7.77M-339.93%-7.64M-463.56%-6.4M58.81%-3.42M-12.44%-3.1M32.74%-1.74M134.36%1.76M-88.28%-8.29M-5,545.02%-2.75M-673.67%-2.58M
Other net revenue -23.74%15.54M15.32%13.02M-11.22%9.44M205.09%25.31M195.14%20.38M289.58%11.29M949.02%10.63M-42.65%8.3M-11.51%6.9M-11.54%2.9M
Invest income ---------------24.24K---24.24K---24.24K----------------
Asset deal income -26.66%74.56K-51.62%74.8K--32.1K-2,506.63%-978.36K421.82%101.67K589.43%154.62K-----108.92%-37.53K-2,061.53%-31.59K-2,061.53%-31.59K
Other revenue 5.04%28.01M31.94%21.74M110.64%16.18M68.71%34.35M89.79%26.66M65.02%16.48M51.66%7.68M4.53%20.36M20.59%14.05M77.24%9.98M
Operating profit 99.67%703.47M89.61%395.79M277.02%178.15M53.61%424.75M66.33%352.31M106.09%208.74M106.63%47.25M10.56%276.52M-16.14%211.82M-33.89%101.28M
Add:Non operating Income -25.70%183.76K232.97%83.76K--905205.45%291.89K189.07%247.33K-67.57%25.16K-----96.84%95.56K-95.86%85.56K15.26%77.56K
Less:Non operating expense 1.25%14.88M32.40%11.17M-89.05%612.66K158.22%30.01M59.56%14.7M1.67%8.44M408.65%5.6M-40.12%11.62M-46.44%9.21M-42.83%8.3M
Total profit 103.86%688.77M92.04%384.71M326.19%177.53M49.07%395.03M66.69%337.86M115.26%200.33M90.40%41.66M13.38%264.99M-14.64%202.69M-32.93%93.06M
Less:Income tax cost 90.81%89.86M60.88%49.88M358.07%31.64M128.27%56.97M131.32%47.1M484.20%31M173.19%6.91M13.27%24.96M-41.20%20.36M-70.71%5.31M
Net profit 105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M
Net profit from continuing operation 105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M
Net profit of parent company owners 105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M
Earning per share
Basic earning per share 105.04%2.4497.10%1.36315.00%0.8340.58%1.9413.33%1.1935.29%0.6925.00%0.2-19.77%1.38-35.98%1.05-62.77%0.51
Diluted earning per share 105.04%2.4497.10%1.36315.00%0.8339.86%1.9313.33%1.1935.29%0.6925.00%0.2-19.77%1.38-35.98%1.05-62.77%0.51
Other composite income
Total composite income 105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M
Total composite income of parent company owners 105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +0.95%
Sample Name
Sample Code
 -4.39%
Sample Name
Sample Code
 -6.11%
4
CHINA OILFIELD
02883
-6.41%
5
KUNLUN ENERGY
00135
-9.69%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -